Knowledge Hub

Global Cancer Immunotherapies Market to grow at a CAGR of 15.17% during the period 2016-2020.

Press Release   •   May 09, 2016 09:04 EDT

Description

About Cancer Immunotherapies

Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.

Technavios analysts forecast the Global Cancer Immunotherapies Market to grow at a CAGR of 15.17% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Free Sample of this Report

Key vendors

Amgen

Bristol-Myers Squibb

F. Hoffmann-La Roche

GlaxoSmithKline

Merck

Takeda Pharmaceuticals

Other prominent vendors

AbbVie

ADC Therapeutics

Agensys

Astellas

AstraZeneca

Bayer

Biogen

Biotech Pharmaceutical

Boehringer-Ingelheim

Celgene

Celldex Therapeutics

Chugai Pharmaceutical

CTI Biopharma

Daiichi Sankyo

Eli Lilly

Fortress Biotech

Genmab

Immunomedics

Intas Pharmaceuticals

Janssen Biotech

Kyowa Hakko Kirin

MedImmune

Morphotek

Neovii Biotech

Novartis

OncoMed Pharmaceuticals

Pfizer

Sanofi

Seattle Genetics

Spectrum Pharmaceuticals

TG Therapeutics

XBiotech

Market driver

Increase in demand for cancer monoclonal antibodies

For a full, detailed list, view our report

Market challenge

Patent expiry of top-selling drugs

For a full, detailed list, view our report

Market trend

Emergence of targeted and combination therapies

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?